Answers are grounded in this paper and cite their sources.
: There is light on the horizon that new treatment options will be available in due time, as there are several promising therapeutic agents currently under investigation, some being at the first levels of drug development, but some already in ongoing clinical trials (phase I-III).
No takes yet. Share an insight, caveat, or question.
Weigert et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: